Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha (Henna) ointment vs hydrocortisone for radiation-induced dermatitis
IRCT201206099979N1Phase 2Completed
- Sponsor
- Vice chancellor for research,, Shiraz University of Medical Sciences
- Start
- Jan 2012
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of alpha ointment and hydrocortisone in radiodermatitis (2 arms), sponsored by Vice chancellor for research,, Shiraz University of Medical Sciences. Primary endpoint: Severity of radiation-induced skin reaction. Started Jan 2012; status: completed.
02
Drugs
alpha ointmenthydrocortisone
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on IRCT201206099979N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201206099979N1.